BTK and neoplasm: To further evaluate the effect of ibrutinib on BTK phosphorylation in TIL-Bs, we performed mIHC and confirmed the inhibition of BTK phosphorylation in the TIL-Bs of ibrutinib-treated tumor samples (Figure 4B).